Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Parameters for tumor spread between the PDS and NACT group

From: Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study

Parameter PDS group NACT group P value
Pelvic mass ≥ 10 cm 18.4% (26/141) 16.5% (13/79) 0.712
Large volume Ascites (>500 mL) 45.4% (64/141) 45.6% (36/79) 0.980
Multiple peritoneal nodules 56.7%(80/141) 57.0% (45/79) 0.974
Multiple mesenteric nodules 27.0%(38/141) 48.1% (38/79) 0.002
Multiple diaphragm nodules 30.5%(43/141) 43.0% (11/56) 0.061
Omental cake 22.0%(31/141) 79.7% (63/79) < 0.001
Multisectional intestinal infiltration ≥3 segments 23.4%(33/141) 12.7% (10/79) 0.054
Multiple liver metastasis 14.9%(21/139) 27.8% (22/79) 0.020
Fusion of enlarged lymph node 4.4%(5/113) 1.6% (1/62) 0.226